rituximab

You have access
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial
Jingjing Wu, Fenghua Gao, Wenhua Wang, Xudong Zhang, Meng Dong, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Linan Zhu, Mengjie Ding, Songtao Niu, Zhaoming Li, Yu Chang, Feifei Nan, Jiaqian Yan, Hui Yu, Xiaolong Wu, Zhiyuan Zhou, Jieming Zhang and Mingzhi Zhang

Cancer Biology & Medicine July 2022, 19 (7) 1089-1099; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0026
You have access
CHOP-like Regimen in Combination with Rituximab and Peginterferon Alpha-2b in Newly-diagnosed Diffuse Large B-cell Non-Hodgkin’s Lymphoma: Experience in a Chinese Center
Shu-qing LÜ, Jian-min YANG, Xian-min SONG, Li CHEN, Wei-ping ZHANG, Xiao-qian XU, Xiong NI, Chong-mei HUANG, Yi HE and Jian-min WANG

Clinical Oncology and Cancer Research April 2010, 7 (2) 103-109; DOI: https://doi.org/10.1007/s11805-010-0503-2
You have access
Rituximab in Combination with CHOP, an Effective and Well-tolerated Salvage Regimen for Diffuse Large B-Cell Lymphoma
Yong Guan, Zhenxia Lu, Butong Sun, Lintao Bi and Pengyu Zhang

Chinese Journal of Clinical Oncology August 2007, 4 (4) 264-267; DOI: https://doi.org/10.1007/s11805-007-0264-8

Main menu